CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biohit Oyj Company Snapshot
Biohit Oyj operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other pharmaceutical manufacturers in Europe: Farmsintez PAO of Russia (2017 sales of 723.50 million Russian Rubles [US$10.62 million] ), Medincell SA of France (8.53 million Euro [US$9.63 million] ), and Onxeo SA which is also based in France (9.51 million Euro [US$10.73 million] ).

Sales Analysis. Biohit Oyj reported sales of 8.98 million Euro (US$10.13 million) for the year ending December of 2017. This represents an increase of 9.6% versus 2016, when the company's sales were 8.20 million Euro. Sales at Biohit Oyj have increased during each of the previous five years (and since 2012, sales have increased a total of 338%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biohit Oyj
  Stock Performance Chart for Biohit Oyj
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 3.48
(Figures in Euro)
1 Week 0.6%   13 Weeks -10.1%  
4 Weeks -27.5%   52 Weeks -25.3%  
 
Biohit Oyj Key Data:
  Ticker: BIOBV Country: Finland
  Exchanges: HEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 8,979,000
(Year Ending Jan 2018).
Employees: 42
  Currency: Euro Market Cap: 51,814,687
  Fiscal Yr Ends: December Shares Outstanding: 14,889,278
  Share Type: B Osake Closely Held Shares: 8,238,618
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.